期刊文献+

宁夏地区回族女性散发性乳腺癌易感基因BRCA1/BRCA2突变的研究 被引量:4

BRCA1 and BRCA2 gene mutation in sporadic cases of Hui nationality with breast cancer in Ningxia area
下载PDF
导出
摘要 目的研究宁夏地区回族女性散发性乳腺癌中BRCA1/BRCA2基因(breast cancer susceptibility gene 1/2)的突变位点及携带情况。方法收集60例回族居民乳腺癌石蜡包埋组织标本及15例乳腺小叶增生或纤维腺瘤标本。PCR和DNA直接测序法检测BRCA1基因第2、11和20号外显子和BRCA2基因第11号部分外显子突变情况。结果 60例乳腺癌BRCA1基因有10例突变,突变率为16.7%,突变位点均位于BRCA1基因。15例对照均未检出突变且淋巴结转移与未转移组间BRCA1基因突变率差异(30.8%与5.9%)有统计学意义(P<0.05)。结论 BRCA1基因突变可能与宁夏回族女性乳腺癌发生相关。 Objective To detect the prevalence of mutational sites of breast cancer susceptibility gene 1/2(BRCA1 and BRCA2) in the patients of Hui nationality with breast cancer in Ningxia area.Methods Paraffin imbedding and frozen tissues of breast cancer were collected from 60 breast cancer patients of Hui nationality and 15 cases benign breast diseases.The mutations of three exons(2,11 and 20) of BRCA1 gene and one exon(11) of BRCA2 gene were examined by polymerase chain reaction(PCR) and DNA direct sequencing.Results The mutations of BRCA1 gene were found in 10 of 60 cases(16.67%) of breast caner.No mutation was identified in the controls.There was a significant difference of the mutation rate of BRCA1 gene between lymph node metastasis and non-lymph node metastasis groups(P0.05).Conclusion BRCA1 mutation may play an important role in the risk factors of breast cancer patients of Hui nationality in Ningxia.
出处 《临床检验杂志》 CAS CSCD 北大核心 2011年第4期295-297,共3页 Chinese Journal of Clinical Laboratory Science
基金 宁夏回族自治区科技厅攻关项目(2008年度)
关键词 乳腺癌 BRCA1基因 BRCA2基因 DNA测序 突变 breast cancer breast cancer susceptibility gene gene 1/2 DNA sequencing mutation
  • 相关文献

参考文献11

  • 1Dvorah A, Luna K, Israela L, et al. The founder mutation 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of o- varian cancer and 30% of early-onset breast cancer patients among Ashkenazi women[J]. Am J Genet, 1997,60(3) :505-514.
  • 2David BB, Josephine C, David DS, et al. A Common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals [ J ]. Cancer Res, 1996, 56 ( 15 ) :3409-3414.
  • 3Levy-Lahad E, Catane R, Eisenberg S, et al. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Isreal: frequency and differen- tial penetrance in ovarian cancer and in breast-ovarian cancer families [J]. Am J Hum Genet,1997,60(5) :1059-1067.
  • 4Friedman IS. Ostermeyer EA. Szabo CI, et al. Confirmation of breast and ovarian cancer in ten families [ J ]. Nature Genetics, 1994,8 (4) : 399-404.
  • 5Petr Pohlreich. Michal Zikan. Jana Stribrna, et al. High proportion of recurrent germline mutations in the BRCAlgene in breast and ovarian cancer patients from the Prague area [ J ]. Breast Cancer Research, 2005,7(5) : R728-736.
  • 6宋斌,李慧明,马清洋.宁夏汉民、回民女性乳腺癌临床流行病学调查[J].四川肿瘤防治,2001,14(2):90-91. 被引量:3
  • 7Vaidyanathan K, Lakhotia S, Ravishankar HM, et al. BRCA1 and BRCA2 germline mutation analysis among Indian women from south In- dia:identification of four novel mutations and high-frequency occur- rence of 185delAG mutation [ J ]. J Biosci ,2009,34 (3) :415-422.
  • 8赖春宁,江泽飞,宋三泰,王建安,黎燕,沈倍奋.38例散发乳腺癌患者BRCA1基因突变检测[J].癌症,1999,18(4):389-391. 被引量:10
  • 9付欣鸽,王振华,李锋,胡文浩,米开.热木,蒋金芳,李洪安.110例维吾尔族及汉族乳腺癌中BRCA1基因突变及P53蛋白表达的研究[J].中国组织化学与细胞化学杂志,2007,16(3):340-346. 被引量:6
  • 10王曦,杨名添,方嬿,梁启万,张如华,曾益新.231例乳腺癌患者乳腺癌易感基因BRCA1的突变检测及分析[J].癌症,2001,20(9):916-920. 被引量:12

二级参考文献28

  • 1李士谔.细胞分化在致癌和抑癌中的作用(续)[J].中国医学科学院学报,1994,16(1):73-77. 被引量:9
  • 2宋传贵,胡震,袁文涛,狄根红,沈镇宙,黄薇,邵志敏.上海地区早发性乳腺癌患者BRCA1和BRCA2基因突变分析[J].中华医学杂志,2005,85(43):3030-3034. 被引量:26
  • 3Irminger - Finger I, Siegel BD, Leung WC. The functions of breast cancer susceptibility gene 1 ( BRCA1 ) product and its associated proteins[J]. Biol Chem,1999, 380(2) : 117 -128.
  • 4Armika Berganan, Anna Flodin, Yvonne Engwall, et al. A high frequency of germline BRCA1/2 mutations in western Sweden detec- ted with complementary screening techniques [ J ]. Familial Caneer,2005, 4 (2) : 89 - 96.
  • 5Philippe Maillet, PO,M,et al. Twenty - three novel BRCA1 and BRCA2 sequence variations identified in a cohort of Swiss breast and ovarian cancer families[ J ]. Cancer Genetic and Cytogenesis, 2006, 169 (1) :62- 68.
  • 6Nielsen TO, Hsu FD, Jensen K, et al. clinical characterization of the basal - like subtype of invasive breast carcinoma [ J ]. Clin Cancer Res, 2004, 10 ( 16 ) : 5367 - 5374.
  • 7Banerjee S, Reis - Filho JS, Ashley S, et al. Basal - like breast carcinomas: clinical outcome and response to chemotherapy [ J ]. J Clin Pathol,2006,59(7) :729 -735.
  • 8William DF, Kelly M, Sun P, et al. Estrogen receptor status in BRCAI and BRCA2 -Related breast cancer: the influence of age, grade, and histological type [ J]. Cancer Res, 2004, 10: 2029 - 2034.
  • 9Jose P, Emiliano H, Ana O, et al. istics defined by tissuemicroarray of hereditary breast cancer not at- tributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCAI and BRCA2 mutation carriers [ J ]. Cancer Res, 2003,9: 3606-3610.
  • 10Cipollini G, Tommasi S, Paradiso A, et al. Genetic alterations in hereditary breast cancer [ J ]. Ann Oncol, 2004,15 : 13 - 71.

共引文献28

同被引文献35

  • 1张海添,陆云飞,曾健,林坚,廖清华,万福强.散发性乳腺癌中BRCA1和BRCA2基因突变的研究[J].中华外科杂志,2007,45(7):480-482. 被引量:6
  • 2Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions ( risk factors, screening, and treat- ment) to reduce future rates [ J ]. Cancer,2010, 116 ( 3 ) : 544-573.
  • 3Oldenburg CS, Boll D, Nicolaije KA, et al. The relationship of body mass index with quality of life among endometrial cancer survivors : a study from the population-based PROFILES registry [ J ]. Gynecol Oncol, 2013, 129(1) : 216-221.
  • 4Shah PP, Fong MY, Kakar SS. FFFG induces EMT through integrin AlphaV Beta3-focal adhesion kinase signaling in lung cancer cells [J]. Oncogene, 2012, 31(26) : 3124-3135.
  • 5Feng ZZ, Chen JW, Yang ZR, et al. Expression of FFFG1 and PTEN in endometrial carcinoma:correlation with tumorigenesis and progres- sion[J]. Med Oncol, 2012, 29(1 ): 304-310.
  • 6Reitsma W, Mourits MJ, de Bock GH, et al. Endometrium is not the primary site of origin of pelvic high-grade serous carcinoma in BRCA1 or BRCA2 mutation carriers[J]. Mod Pathol, 2013, 26(4) : 572-578.
  • 7Vicus D, Finch A, Cass I, et al. Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube[J]. Gynecol Oncol, 2010, 118(3) : 299-302.
  • 8Gaengel K, Betsholtz C. Endocytosis regulates VEGF signalling dur- ing angiogenesis[ J]. Nat Cell Biol, 2013, 15(3): 233-235.
  • 9Ruan GX, Kazlauskas A. Axl is essential for VEGF-A-dependent ac- tivation of PI3K/Akt[J]. EMBO J, 2012, 31 (7) : 1692-1703.
  • 10Morikawa T, Baba Y, Yamauchi M, et al. STAT3 expression, mo- lecular features, inflammation patterns, and prognosis in a data- base of 724 colorectal cancers [ J]. Clin Cancer Res, 2011, 17 (6) : 1452-1462.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部